
Michael A. Poch, MD, urologist and assistant member at Moffitt Cancer Center, discusses the potential of nivolumab (Opdivo) as a treatment for patients with metastatic bladder cancer.

Your AI-Trained Oncology Knowledge Connection!


Published: August 26th 2016 | Updated: